Your rapid flu test came back positive, and now your doctor tells you it is either type A or type B. But what does that actually mean for your illness? While both types produce miserable symptoms, flu A vs flu B symptoms differ in important ways that affect severity, treatment decisions, and how long you can expect to be down. Understanding these differences helps you navigate your illness more effectively. For more condition guides, see our medical conditions guide.
Influenza A vs Influenza B: The Basics
Influenza A and influenza B are the two types responsible for seasonal flu epidemics. They are distinct viruses with different characteristics, though both belong to the Orthomyxoviridae family. Influenza A is classified into subtypes based on two surface proteins: hemagglutinin (H) and neuraminidase (N). The currently circulating subtypes in humans are H1N1 and H3N2. Influenza B does not have subtypes but splits into two lineages: Victoria and Yamagata.
According to the CDC, influenza A is responsible for the majority of flu hospitalizations and deaths each year. It infects a broader range of animal hosts (birds, pigs, horses), which gives it more opportunities to mutate and is why influenza A is the type behind all known flu pandemics. Influenza B circulates almost exclusively among humans and tends to cause milder illness in most cases, though it can still be severe, particularly in children.
Comparing Symptoms Side by Side
Both influenza A and influenza B share a core set of symptoms that make clinical differentiation between the two types essentially impossible without laboratory testing. The overlapping symptom profile includes sudden onset of fever (often 100 to 104 degrees Fahrenheit), generalized body aches and myalgia, profound fatigue and malaise, dry or productive cough, sore throat, headache, and nasal congestion or runny nose. The onset is characteristically abrupt: most flu patients can identify the exact hour when they started feeling ill, in contrast to the gradual onset typical of common colds.
That said, meaningful patterns do emerge across large epidemiological studies and clinical surveillance data. Influenza A, particularly the H3N2 subtype, tends to produce higher peak fevers (frequently exceeding 103 degrees Fahrenheit), more severe and debilitating body aches, and greater overall illness severity as measured by hospitalization rates and ICU admissions. Research published in Clinical Infectious Diseases found that hospitalization rates for influenza A infections are roughly two to three times higher than for influenza B infections across most surveillance seasons, with H3N2-dominant seasons consistently producing the most severe outcomes. Respiratory symptoms including persistent cough, chest tightness, and congestion are prominent and often the most lingering symptoms for both types, sometimes persisting for two to three weeks after other symptoms resolve.
Influenza B, while generally producing milder illness in the overall population, more frequently causes gastrointestinal symptoms in children, including nausea, vomiting, abdominal pain, and diarrhea. These GI symptoms can be prominent enough that some parents initially suspect a stomach virus rather than influenza. The American Academy of Pediatrics emphasizes that while flu B is widely perceived as the “milder” flu type, this reputation is misleading and potentially dangerous. Influenza B can cause severe, life-threatening illness in pediatric populations, and certain flu B seasons have produced disproportionately high numbers of pediatric deaths relative to overall flu activity. Flu B also tends to circulate later in the season (February through April), sometimes catching families and healthcare systems off guard after flu A activity has waned.
Which Type Is More Dangerous?
Influenza A generally poses a greater public health threat. It is responsible for more severe illness across all age groups, higher hospitalization rates, and virtually all pandemic flu events in history. The H3N2 subtype in particular has been associated with more severe flu seasons, higher mortality in elderly populations, and greater ICU admissions, according to CDC surveillance data.
However, influenza B should not be dismissed. During the 2019-2020 flu season, influenza B was responsible for a disproportionate share of pediatric flu deaths. Children under 5 and adults over 65 are at elevated risk for complications from both types. Pregnant women, immunocompromised individuals, and people with chronic conditions like asthma, diabetes, and heart disease also face increased risk regardless of flu type.
Treatment Options for Both Types
Antiviral medications are the primary medical treatment for confirmed or strongly suspected influenza infections of either type. Four FDA-approved antiviral drugs are currently available: oseltamivir (Tamiflu), zanamivir (Relenza), peramivir (Rapivab), and baloxavir marboxil (Xofluza). All four are effective against both influenza A and influenza B, though susceptibility patterns can vary by season and circulating strains. The CDC recommends initiating antiviral treatment within 48 hours of symptom onset for the greatest clinical benefit, though treatment started later can still reduce the risk of complications in high-risk patients and those with severe illness.
Oseltamivir is by far the most commonly prescribed antiviral for influenza, available as both a capsule and a liquid suspension suitable for young children. A standard five-day course reduces symptom duration by approximately one to two days when started within the first 48 hours. The most common side effect is nausea, which can be minimized by taking the medication with food. Baloxavir offers the unique convenience of a single-dose treatment, achieving comparable symptom reduction with just one pill. It works through a different mechanism (cap-dependent endonuclease inhibition) than oseltamivir (neuraminidase inhibition), which means it remains effective against some oseltamivir-resistant strains. Zanamivir is an inhaled powder and is less commonly used, partly due to the device coordination required and its contraindication in patients with asthma or COPD. Peramivir is administered as a single intravenous infusion and is typically reserved for hospitalized patients who cannot take oral medications.
Your doctor will select the most appropriate antiviral based on your age, symptom severity, time since onset, underlying health conditions, and any known drug allergies or contraindications. For most outpatients, oseltamivir or baloxavir are the practical first-line choices. Cost varies: generic oseltamivir is relatively affordable, while brand-name baloxavir carries a higher price point but may be worth the convenience for some patients.
Supportive care remains essential regardless of whether antiviral medications are prescribed. Rest allows your immune system to mount an effective response. Hydration prevents the dehydration that fever, sweating, and reduced oral intake can produce. Acetaminophen (Tylenol) or ibuprofen (Advil, Motrin) manage fever and body aches effectively. Aspirin must be avoided in children and teenagers with influenza due to the risk of Reye syndrome, a rare but potentially fatal complication. Monitoring for signs of complications, including worsening symptoms after initial improvement, difficulty breathing, persistent chest pain, and inability to maintain hydration, is the critical safety component of home management.
When to See a Doctor
Most healthy adults and older children recover from the flu at home within one to two weeks. However, certain warning signs indicate potential complications that need medical evaluation. Seek care if symptoms improve then suddenly worsen (suggesting a secondary bacterial infection), if fever persists beyond five days, if breathing becomes difficult or painful, if dehydration develops (reduced urination, dry mouth, dizziness), or if chest pain or pressure develops.
For infants, children, and high-risk adults, earlier medical evaluation is advisable. A telehealth visit can help determine whether in-person evaluation or antiviral treatment is warranted, often getting a prescription called in to your pharmacy the same day.
When to seek emergency care: Call 911 or go to the nearest emergency room for difficulty breathing or shortness of breath, persistent chest pain or pressure, confusion, inability to keep fluids down, bluish lips or face, severe muscle pain, or seizures. In infants, watch for inability to eat, no tears when crying, and significantly fewer wet diapers than normal.
Prevention: Vaccines Cover Both Types
The annual influenza vaccine is specifically formulated each year to protect against both major influenza A subtypes (H1N1 and H3N2) and influenza B lineages. Quadrivalent vaccines, which have become the universal standard in the United States, cover all four circulating strain groups in a single shot. The CDC recommends annual vaccination for everyone 6 months and older, with optimal timing in September or October before flu activity typically begins escalating in late fall and peaks between December and February.
Vaccine effectiveness varies by season depending on how well the selected vaccine strains match the strains that actually circulate. In a well-matched year, effectiveness typically ranges from 40 to 60 percent in preventing medically attended influenza illness. Effectiveness tends to be higher against influenza B than influenza A, and H3N2 seasons tend to produce lower vaccine effectiveness due to that subtype’s rapid antigenic drift (the constant minor mutations in surface proteins that allow it to partially evade vaccine-generated immunity).
Even when the vaccine does not prevent infection entirely, vaccination significantly and consistently reduces the risk of severe illness requiring hospitalization, ICU admission, and death. This benefit is particularly important for high-risk populations: young children, adults over 65, pregnant women, and individuals with chronic health conditions. A CDC analysis estimated that flu vaccination prevented approximately 100,000 hospitalizations and 7,000 deaths during a recent moderate-severity season. For individuals who contract influenza despite vaccination, the illness tends to be milder in severity and shorter in duration compared to unvaccinated individuals with the same strain.
Beyond vaccination, basic infection prevention measures help limit flu transmission: frequent handwashing with soap and water for at least 20 seconds, covering coughs and sneezes with a tissue or elbow, avoiding touching your face, staying home when symptomatic, and maintaining distance from known flu cases when possible. These measures are not glamorous, but combined with vaccination, they form the most effective protection available against both influenza A and influenza B.
Frequently Asked Questions
Can you have flu A and flu B at the same time?
Co-infection with both types is possible but rare. When it occurs, illness may be more severe. Rapid flu tests can detect both types, and your doctor would treat the same way: with antivirals and supportive care.
How long is the flu contagious?
Most adults are contagious from one day before symptoms start through five to seven days after becoming sick. Children and immunocompromised individuals may be contagious for longer. The CDC recommends staying home until you have been fever-free for at least 24 hours without fever-reducing medications.
Does flu B last longer than flu A?
Both types typically cause acute illness lasting 5 to 10 days, with residual fatigue and cough sometimes persisting for two weeks or more. There is no consistent evidence that one type has a significantly longer duration than the other in uncomplicated cases.
Is the stomach flu actually influenza?
No. “Stomach flu” is a colloquial term for gastroenteritis, which is usually caused by norovirus or rotavirus, not influenza. While influenza can cause GI symptoms (particularly flu B in children), true influenza primarily affects the respiratory system.
Complications to Watch For
Both influenza A and B can lead to complications that extend the illness beyond the typical one-to-two-week course. Pneumonia is the most common serious complication, occurring either as primary viral pneumonia from the influenza itself or as secondary bacterial pneumonia when bacteria exploit the virus-damaged airway lining. According to the CDC, secondary bacterial pneumonia is a leading cause of influenza-related death, particularly in the elderly and those with chronic lung disease.
Other complications include sinus infections, ear infections (especially in children), myocarditis (inflammation of the heart muscle), encephalitis (brain inflammation), myositis (muscle inflammation that can cause severe leg pain and difficulty walking, particularly in children with influenza B), and worsening of existing chronic conditions like asthma, COPD, diabetes, and heart failure. Reye syndrome, though rare, is a potentially fatal complication associated with aspirin use in children during influenza illness, which is why aspirin is absolutely contraindicated in pediatric flu patients.
The Bottom Line
Both influenza A and flu B make you genuinely miserable, but flu A generally causes more severe illness across the population and drives the majority of hospitalizations and deaths. Regardless of which type you have, the treatment approach follows the same evidence-based framework: antiviral medication initiated within 48 hours of symptom onset when possible, consistent supportive care including rest and hydration, and vigilant monitoring for the warning signs of complications. Annual vaccination remains your single best defense against both types, and its benefits extend beyond personal protection to reducing community transmission. If you are unsure whether your symptoms warrant medical attention, err on the side of getting evaluated, especially for young children, adults over 65, pregnant women, and anyone with underlying chronic health conditions.